| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |